ACTR-51. REMARKABLE RESPONSE OF A PATIENT WITH SECONDARY GBM TO A HISTONE DEACETYLASE INHIBITOR

Glioblastomas are highly aggressive, grade IV tumors of glial cells that arise either as de novo primary tumors or as secondary tumors, which malignantly transformed from lower grade gliomas. Secondary glioblastomas have a relatively low incidence making up 5–10% of all glioblastoma diagnoses and te...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Shu, Hui-Kuo, Gurbani, Saumya, Ramesh, Karthik, Weinberg, Brent, Voloschin, Alfredo, Olson, Jeffrey, Shim, Hyunsuk
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Adult Clinical Trials - Non-Immunologic
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846946/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.093
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak